drugset / Trial / NCT03618316
Effect of Cimetidine on the PK of Imeglimin
NaSingle-groupOpen-labelOther
Summary
The trial is an open-label assessment of the interaction of imeglimin with cimetidine. Up to 16 healthy men and women will receive a single oral dose of 1,500 mg imeglimin alone followed by a second dose of imeglimin during repeated doses of 400 mg cimetidine taken twice daily for 6 days.
Timeline
- Start
- 2018-06-19
- Primary completion
- 2018-07-21
- Completion
- 2018-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cimetidine | Small molecule | 400 mg | — |
| Subject | Imeglimin | Small molecule | 1500 mg | Oral |
Indications
No indication recorded.